- Report
- April 2024
- 50 Pages
Global
From €2562EUR$2,650USD£2,201GBP
- Report
- April 2024
- 50 Pages
Global
From €2562EUR$2,650USD£2,201GBP
- Report
- April 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- February 2024
- 150 Pages
Global
From €4109EUR$4,250USD£3,529GBP
- Report
- February 2024
- 188 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- January 2023
- 130 Pages
Global
From €5752EUR$5,950USD£4,941GBP
- Report
- May 2018
- 70 Pages
Global
From €2804EUR$2,900USD£2,408GBP
- Report
- January 2023
- 167 Pages
Global
From €3480EUR$3,600USD£2,990GBP
- Report
- January 2023
- 85 Pages
Asia Pacific
From €1450EUR$1,500USD£1,246GBP
- Report
- April 2023
- 156 Pages
Global
€4834EUR$5,000USD£4,152GBP
- Report
- April 2023
- 114 Pages
Global
€3384EUR$3,500USD£2,906GBP
- Report
- April 2023
- 109 Pages
Global
€3384EUR$3,500USD£2,906GBP
- Report
- January 2024
- 107 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- April 2024
- 50 Pages
Global
From €2562EUR$2,650USD£2,201GBP
- Report
- February 2020
- 207 Pages
Global
From €5192EUR$5,370USD£4,459GBP
- Report
- March 2023
- 147 Pages
Global
From €5800EUR$5,999USD£4,982GBP
Albuterol is a medication used to treat and prevent bronchospasm in people with asthma, chronic obstructive pulmonary disease (COPD), and other breathing disorders. It is a short-acting β2-adrenergic receptor agonist, which works by relaxing the muscles of the airways and increasing airflow to the lungs. Albuterol is available in both oral and inhaled forms, and is often used in combination with other medications to treat respiratory conditions.
Albuterol is one of the most commonly prescribed respiratory drugs, and is widely used in both the United States and Europe. It is available in both generic and brand-name formulations, and is often used in combination with other medications to treat asthma and COPD. In addition, albuterol is used to treat acute exacerbations of COPD, and is also used to prevent exercise-induced bronchospasm.
Some companies in the Albuterol market include GlaxoSmithKline, Merck, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more